113,155 Shares of Procter & Gamble Company (The) $PG Acquired by NBT Bank N.A.

NBT Bank N.A. acquired a new position in shares of Procter & Gamble Company (The) (NYSE:PG) during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund acquired 113,155 shares of the company’s stock, valued at approximately $16,439,000. Procter & Gamble makes up about 1.1% of NBT Bank N.A.’s investment portfolio, making the stock its 17th biggest position.

Other institutional investors and hedge funds also recently modified their holdings of the company. Ellis Investment Partners LLC raised its holdings in shares of Procter & Gamble by 0.7% during the 3rd quarter. Ellis Investment Partners LLC now owns 8,816 shares of the company’s stock valued at $1,281,000 after buying an additional 64 shares during the period. Clark Wealth Partners lifted its position in Procter & Gamble by 20.6% during the 3rd quarter. Clark Wealth Partners now owns 387 shares of the company’s stock worth $56,000 after acquiring an additional 66 shares in the last quarter. KLCM Advisors Inc. boosted its holdings in Procter & Gamble by 0.9% in the 1st quarter. KLCM Advisors Inc. now owns 7,890 shares of the company’s stock worth $1,140,000 after acquiring an additional 70 shares during the period. Midwest Professional Planners LTD. boosted its holdings in Procter & Gamble by 2.6% in the 2nd quarter. Midwest Professional Planners LTD. now owns 2,799 shares of the company’s stock worth $410,000 after acquiring an additional 70 shares during the period. Finally, Legacy Solutions LLC boosted its holdings in Procter & Gamble by 3.8% in the 2nd quarter. Legacy Solutions LLC now owns 1,928 shares of the company’s stock worth $283,000 after acquiring an additional 71 shares during the period. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Insider Activity at Procter & Gamble

In other news, insider Marc S. Pritchard sold 4,030 shares of the stock in a transaction that occurred on Thursday, August 20th. The stock was sold at an average price of $143.79, for a total transaction of $579,473.70. Following the completion of the transaction, the insider directly owned 187,001 shares in the company, valued at approximately $26,888,873.79. This represents a 2.11% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Paul Gama sold 2,225 shares of the firm’s stock in a transaction that occurred on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $323,381.50. Following the sale, the chief executive officer directly owned 51,124 shares of the company’s stock, valued at $7,430,362.16. The trade was a 4.17% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders sold 15,135 shares of company stock worth $2,189,970 over the last ninety days. Company insiders own 0.23% of the company’s stock.

Procter & Gamble Stock Up 5.8%

Shares of NYSE PG opened at $165.94 on Friday. Procter & Gamble Company has a 1 year low of $137.62 and a 1 year high of $167.25. The firm has a market cap of $385.41 billion, a price-to-earnings ratio of 25.07, a PEG ratio of 3.90 and a beta of 0.39. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68. The stock’s 50-day simple moving average is $148.08 and its 200-day simple moving average is $146.99.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Thursday, October 22nd. The company reported $2.00 EPS for the quarter, topping the consensus estimate of $1.89 by $0.11. The business had revenue of $23.28 billion for the quarter, compared to analysts’ expectations of $22.80 billion. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%. The company’s revenue was up 4.0% compared to the same quarter last year. During the same quarter in the previous year, the firm posted $1.99 earnings per share. As a group, equities analysts anticipate that Procter & Gamble Company will post 6.98 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, November 16th. Shareholders of record on Friday, October 23rd will be paid a dividend of $1.0885 per share. This represents a $4.35 dividend on an annualized basis and a yield of 2.6%. The ex-dividend date is Friday, October 23rd. Procter & Gamble’s dividend payout ratio (DPR) is 65.71%.

Analysts Set New Price Targets

PG has been the subject of several recent research reports. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, September 21st. TD Cowen reissued a “hold” rating and set a $150.00 target price on shares of Procter & Gamble in a research report on Wednesday, September 30th. HSBC reissued a “hold” rating and set a $149.00 target price (down from $182.00) on shares of Procter & Gamble in a research report on Thursday, July 30th. Sanford C. Bernstein restated a “market perform” rating and issued a $149.00 target price on shares of Procter & Gamble in a research note on Monday, August 24th. Finally, JPMorgan Chase & Co. lowered their price target on shares of Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating for the company in a report on Thursday, July 16th. Fourteen analysts have rated the stock with a Buy rating and ten have assigned a Hold rating to the company’s stock. According to MarketBeat.com, Procter & Gamble currently has an average rating of “Moderate Buy” and an average target price of $162.50.

Trending Headlines about Procter & Gamble

Here are the key news stories impacting Procter & Gamble this week:

• Positive Sentiment: Fiscal Q1 earnings per share came in at $2.00, above the roughly $1.89 analyst consensus, while revenue rose 4% year over year to $23.28 billion, exceeding expectations of approximately $22.80 billion. Procter & Gamble earnings beat as sales rise 4%
• Positive Sentiment: Organic sales increased 4%, supported by volume growth, favorable product mix and productivity savings. Laundry and home-care products were highlighted as key contributors. P&G Q1 Earnings Beat on Volume Growth & Favorable Mix
• Positive Sentiment: P&G raised its fiscal 2027 all-in sales-growth outlook, primarily reflecting the acquisition of Thorne. Management also reiterated its broader full-year revenue forecast, reducing concern that consumer weakness would derail the business. Procter & Gamble Boosts FY27 All-in-sales Growth Outlook
• Positive Sentiment: Investors appeared to favor P&G’s defensive characteristics as broader markets weakened, while increased call-option activity reflected stronger near-term trading interest. P&G Jumps as Earnings Beat Draws Defensive Buyers
• Neutral Sentiment: Management said changing demographics may support premium baby-care demand: fewer children per household can lead parents to spend more on each child, benefiting products such as Pampers. Americans are having fewer babies and pampering them with luxury diapers
• Negative Sentiment: Higher commodity and fuel costs are expected to create an approximately $1.4 billion annual profit headwind, which could pressure margins even as sales remain healthy. P&G flags bigger hit to annual profit from higher commodity costs

Procter & Gamble Profile

Procter & Gamble Company (NYSE: PG) is a global consumer products company that develops, manufactures and markets branded products used in households and personal care. Its portfolio includes personal health and grooming products, beauty and skin care items, baby, feminine and family care products, fabric and home care products, and oral care products.

The company’s well-known brands include Pampers, Tide, Gillette, Crest, Oral-B, Head & Shoulders, Pantene, Olay, Old Spice, Dawn, Febreze and Mr.